Assembly Member Rogers' prescription drug pricing legislation aims to prevent manufacturers from imposing restrictions when healthcare entities purchase discounted medications through contract pharmacies. The measure would prohibit drug manufacturers from creating additional conditions or limitations that interfere with covered entities' ability to obtain and distribute drugs that qualify for federal pricing discounts when working with specified pharmacies to serve eligible patients.
The bill builds upon existing federal requirements that establish price ceilings for outpatient drugs under Medicaid and state laws governing how covered entities dispense these medications. Under the proposed policy, manufacturers could not deny or restrict a covered entity's drug purchases based on their use of contract pharmacies. This maintains covered entities' flexibility to work with various pharmacy partners while preserving access to federally-mandated drug discounts.
The measure addresses the relationship between drug manufacturers, healthcare providers, and pharmacies without requiring new state spending or establishing additional regulatory bodies. While the bill creates new obligations for manufacturers regarding their distribution practices, it relies on existing oversight mechanisms rather than creating new enforcement structures or penalties.
![]() Cecilia Aguiar-CurryD Assembly Member | Committee Member | Not Contacted | |
![]() Heath FloraR Assembly Member | Committee Member | Not Contacted | |
![]() Joaquin ArambulaD Assembly Member | Committee Member | Not Contacted | |
![]() Mia BontaD Assembly Member | Committee Member | Not Contacted | |
![]() Dawn AddisD Assembly Member | Committee Member | Not Contacted |
This bill was recently introduced. Email the authors to let them know what you think about it.
Assembly Member Rogers' prescription drug pricing legislation aims to prevent manufacturers from imposing restrictions when healthcare entities purchase discounted medications through contract pharmacies. The measure would prohibit drug manufacturers from creating additional conditions or limitations that interfere with covered entities' ability to obtain and distribute drugs that qualify for federal pricing discounts when working with specified pharmacies to serve eligible patients.
The bill builds upon existing federal requirements that establish price ceilings for outpatient drugs under Medicaid and state laws governing how covered entities dispense these medications. Under the proposed policy, manufacturers could not deny or restrict a covered entity's drug purchases based on their use of contract pharmacies. This maintains covered entities' flexibility to work with various pharmacy partners while preserving access to federally-mandated drug discounts.
The measure addresses the relationship between drug manufacturers, healthcare providers, and pharmacies without requiring new state spending or establishing additional regulatory bodies. While the bill creates new obligations for manufacturers regarding their distribution practices, it relies on existing oversight mechanisms rather than creating new enforcement structures or penalties.
![]() Cecilia Aguiar-CurryD Assembly Member | Committee Member | Not Contacted | |
![]() Heath FloraR Assembly Member | Committee Member | Not Contacted | |
![]() Joaquin ArambulaD Assembly Member | Committee Member | Not Contacted | |
![]() Mia BontaD Assembly Member | Committee Member | Not Contacted | |
![]() Dawn AddisD Assembly Member | Committee Member | Not Contacted |